Cutibacterium acnes (Propionibacterium acnes): Classification, Morphology, Pathogenesis, Diagnosis & Treatment

Table of Contents

• Introduction
• Classification
• Morphology
• Microscopy
• Cultural and Growth Characteristics
• Epidemiology
• Pathogenesis
• Virulence Factors
• Clinical Manifestations
• Laboratory Diagnosis
• Treatment
• Prevention
• References

Introduction to Cutibacterium acnes

• The skin is the largest organ of the human body and acts as both a physical and immunological barrier against the external environment.
• Despite its strong immune defenses, the skin provides a suitable environment for the colonization of diverse microorganisms.
• Because of its large surface area, the skin hosts a complex microbial community known as the skin microbiome, which includes:
• Bacteria
• Viruses
• Fungi
• Demodex mites
• The skin microbiome consists of these microorganisms and their associated genetic material, forming a dynamic ecosystem that interacts with the host.
• One of the important bacterial members of the skin microbiome is Cutibacterium acnes, formerly known as Propionibacterium acnes.
• C. acnes is primarily associated with human skin, where it commonly colonizes areas rich in sebaceous glands. It can also be found in the gastrointestinal tract.
• C. acnes and acne vulgaris are closely associated. Acne vulgaris is among the most common skin diseases, particularly affecting areas with a high density of sebaceous glands.
• Microbial factors are considered an important component of acne development, although the precise etiology and pathogenesis of acne vulgaris remain incompletely understood.
• Importantly, current evidence suggests that acne is not simply caused by the presence of C. acnes. Instead, changes in the composition and balance of the skin microbial community may contribute to disease development.
• In particular, reduced microbial diversity and an imbalance among different C. acnes phylotypes have been associated with acne.
• Therefore, the relationship between C. acnes and acne is better understood in terms of microbial diversity, strain/phylotype composition, and interactions within the skin microbiome, rather than considering C. acnes as a uniformly pathogenic species.

Classification of Cutibacterium acnes

• Kingdom: Bacteria
• Phylum: Actinomycetota
• Class: Actinomycetia
• Order: Propionibacteriales
• Family: Propionibacteriaceae
• Genus: Cutibacterium
• Species: Cutibacterium acnes

Taxonomic History

• Following its initial isolation, the organism now known as Cutibacterium acnes underwent several taxonomic reclassifications.
• It was initially placed in the genus Bacillus and named Bacillus acnes.
• It was subsequently transferred to the genus Corynebacterium, becoming Corynebacterium acnes.
• The organism was later classified within the genus Propionibacterium, largely because of its ability to produce propionic acid through anaerobic carbohydrate metabolism.
• It was therefore known for many years as Propionibacterium acnes.
• In 2016, the species was transferred from Propionibacterium to the newly established genus Cutibacterium. The name was changed to Cutibacterium acnes to better reflect its close association with the human skin microbiome.

Classification of the Genus Cutibacterium

• Cutibacterium belongs to the phylum Actinomycetota and is part of the broader group historically referred to as Actinobacteria.
• Members of the genus Cutibacterium can broadly be divided into two groups:
• “Classic” or “dairy” species, which are primarily associated with dairy products and related environments.
• “Skin” species, which are predominantly associated with the surface of human skin.
• C. acnes belongs to the skin-associated group and is an important member of the normal human skin microbiota.

Morphology of Cutibacterium acnes

• Cutibacterium acnes is a commensal, lipophilic, Gram-positive bacterium that commonly inhabits human skin, particularly sebaceous gland-rich areas.
• The organism is described as diphtheroid or coryneform because of its characteristic rod-shaped, slightly curved morphology.
• Individual cells are approximately 0.4–0.7 µm wide.
• C. acnes is classified as an anaerobic bacterium, meaning it does not require atmospheric oxygen for growth. However, it is more accurately described as an aerotolerant anaerobe because it possesses enzymatic mechanisms that help detoxify reactive oxygen species.
• This oxygen tolerance allows C. acnes to survive and persist on the skin surface, despite exposure to atmospheric oxygen.
• On Gram staining, C. acnes appears Gram-positive and violet to purple because its thick peptidoglycan-rich cell wall retains the crystal violet–iodine complex.
• Microscopically, the cells may occur:
• Singly
• In pairs
• In short chains
• Occasionally in irregular clusters, particularly in specimens obtained from sebaceous-rich tissues
• C. acnes is non-motile because it lacks flagella. The absence of flagella is a useful morphological characteristic that distinguishes it from some other Gram-positive rods possessing motility-associated structures.
• C. acnes does not form spores, which is another important characteristic used in its identification.
• Many C. acnes strains can produce extracellular polymeric substances (EPS), which contribute to biofilm formation. Biofilm production can support bacterial persistence and may influence interactions between C. acnes and the host.

Microscopy of Cutibacterium acnes

• Gram-stain appearance: Under a light microscope, Cutibacterium acnes appears as a small Gram-positive bacillus that retains the crystal violet–iodine complex because of its thick peptidoglycan-rich cell wall, giving the cells a violet to purple appearance.
• Cell morphology: In clinical smears, C. acnes is commonly observed as short rods or diphtheroid-like cells. The cells may exhibit an irregular or pleomorphic morphology, depending on the growth conditions, incubation period, and type of specimen.
• Effect of growth conditions: C. acnes is best visualized following anaerobic cultivation. Under suitable anaerobic conditions, the organism generally maintains its characteristic short-rod morphology, although mild pleomorphism may develop as the culture ages or when nutrient availability changes.
• Pleomorphism: Variation in cell shape can be influenced by the duration of incubation and nutrient availability. Therefore, cells from different growth stages may not appear completely uniform microscopically.
• Cell arrangement: Microscopically, the cells may occur singly, in pairs, or in short irregular groupings, contributing to the characteristic diphtheroid-like appearance.
• Biofilm-associated morphology: In pathological settings such as acne vulgaris and implant-associated infections, microscopy may reveal dense bacterial aggregates associated with biofilm-like extracellular material. These organized bacterial communities can contribute to persistence within the affected site.
• Overall microscopic identification: The combination of small Gram-positive, short rod/coryneform or diphtheroid-like cells, variable pleomorphism, and purple Gram-stain reaction provides characteristic microscopic features of C. acnes.

🔬 Interactive Morphology of Cutibacterium acnes

Explore the microscopic features that identify this skin-associated bacterium.

Microscopic View Gram-positive cells

Approx. microscopic scale

Purple-staining, pleomorphic/coryneform rods are visible under microscopy.

1

Gram-positive staining

Cutibacterium acnes is a Gram-positive bacterium. Its thick, peptidoglycan-rich cell wall allows it to retain the crystal violet–iodine complex during Gram staining, producing a violet-purple appearance.

Why purple? A thick peptidoglycan-rich cell wall helps retain the crystal violet–iodine complex.

🧫 Morphological profile of Cutibacterium acnes

Gram-positive Pleomorphic / coryneform rod ~0.4–0.7 µm wide Non-motile Non-spore-forming Aerotolerant anaerobe Lipophilic Biofilm-forming

Cultural and Growth Characteristics of Cutibacterium acnes

• General growth characteristics: Cutibacterium acnes is a slow-growing, Gram-positive, non-spore-forming, anaerobic bacterium that is also relatively aerotolerant. It can withstand limited oxygen exposure, but optimal growth generally occurs under anaerobic conditions.
• Oxygen requirements: Although C. acnes is classified as an anaerobe, its ability to tolerate oxygen allows it to persist in oxygen-variable environments such as the pilosebaceous units of human skin. In laboratory culture, anaerobic conditions generally provide the most suitable environment for recovery.
• Growth rate and incubation: C. acnes grows considerably more slowly than many commonly encountered bacterial pathogens. Colonies may become visible after approximately 5–10 days of incubation, while some clinical isolates, particularly from deep or implant-associated specimens, may require 14–21 days for recovery. Therefore, cultures suspected of containing C. acnes may require prolonged incubation to avoid missing clinically relevant growth.
• Culture media: The organism grows more readily on enriched culture media, including blood-containing media, when appropriate anaerobic conditions are provided.
• Colony morphology: On solid media such as blood agar, C. acnes typically produces small, round to slightly irregular, smooth, opaque colonies. Colonies are generally white to grayish and may become more apparent after prolonged incubation.
• Growth in nutrient-limited environments: C. acnes can persist under low-nutrient and low-oxygen conditions, reflecting its adaptation to the nutrient and oxygen gradients found within skin-associated niches.
• Cell envelope and lipid content: The cell envelope of C. acnes contains peptidoglycan and various lipids, including phosphatidylinositol and triglycerides. Its peptidoglycan structure differs from that of many other Gram-positive bacteria and contains L-alanine, D-alanine, and diaminopimelic acid within its peptide components.
• Biofilm formation: C. acnes can form biofilms composed of bacterial cells embedded within extracellular polymeric material. Biofilm growth can promote bacterial persistence by providing a protected microenvironment and may reduce susceptibility to antimicrobial agents and host immune mechanisms.
• Clinical relevance of slow growth: The prolonged incubation required for recovery is particularly important in implant-associated and other deep-seated infections, where C. acnes may be present in low numbers. Failure to maintain cultures for an adequate period can contribute to failure to recover the organism.
• Overall cultural profile: The characteristic laboratory profile of C. acnes includes slow growth, preference for anaerobic conditions, small white-to-grayish colonies on enriched media, persistence under oxygen- and nutrient-limited conditions, and the ability to form biofilms.

🧫 Explore the Culture of Cutibacterium acnes

Adjust laboratory conditions and observe how incubation, oxygen availability, nutrients and biofilm formation influence the simulated culture.

⏱ Incubation period 2 days

🫧 Oxygen availability High

🥣 Nutrient availability Enriched

🧬 Biofilm tendency Off

Virtual Blood Agar Plate Minimal growth

Anaerobic culture

Early incubation: colonies may not yet be visible because C. acnes is a slow-growing organism.

CULTURAL CHARACTERISTICS

Slow-growing anaerobe

Cutibacterium acnes grows slowly and is best recovered under anaerobic conditions. Its colonies may require several days before becoming visible.

Growth rate Slow

Oxygen preference Anaerobic

Colony appearance Not yet visible

Biofilm Not activated

Relative visible growth 5%

💡 Increase the incubation period and reduce oxygen availability to create conditions more suitable for C. acnes recovery.

🔬 Key cultural profile of Cutibacterium acnes

Slow-growing Anaerobic Aerotolerant Enriched media Blood agar White–grayish colonies Prolonged incubation Biofilm formation

🧫 Cutibacterium acnes Culture Explorer

Explore culture media, colony appearance, incubation time, oxygen conditions and biofilm-associated growth of Cutibacterium acnes.

Day 10

Blood agar • Anaerobic incubation

Blood Agar

Colony appearance Small, round, smooth, opaque white to grayish colonies.

Growth requirement Slow growth with prolonged incubation under anaerobic conditions.

Typical laboratory observation Visible colonies may require several days of incubation.

💡 Key point: Because C. acnes is slow-growing, cultures should not be discarded too early when clinical suspicion remains.

⏱️ Simulate Incubation Time

Day 1 Day 5 Day 10 Day 15 Day 21

🧫 Small colonies ⚪ White–gray appearance 🕐 Slow growth 🫧 Biofilm-associated growth 🧪 Enriched media 🫙 Anaerobic conditions

Epidemiology of Cutibacterium acnes

• Global occurrence of acne: Acne vulgaris is one of the most common dermatological conditions worldwide, affecting approximately 79–95% of people at some point in life. It is a chronic inflammatory skin disorder associated with follicular hyperkeratinization, increased sebum production, microbial changes, and inflammation, with Cutibacterium acnes playing an important role in disease development.
• Age of onset: Acne commonly begins during adolescence and young adulthood, coinciding with hormonal changes and increased sebaceous gland activity.
• Sex distribution: Acne affects both males and females, although it is generally reported more frequently in females.
• Normal skin colonizer: C. acnes is a natural and abundant member of the human skin microbiota. Under normal conditions, it contributes to the microbial ecosystem of the skin and participates in maintaining the local microbial environment.
• Opportunistic pathogenic potential: Although usually a harmless commensal, C. acnes can alter its local environment under certain conditions and is associated with diseases such as acne vulgaris and implant-associated infections.
• Near-universal skin distribution: Colonization by C. acnes is nearly universal in humans. The bacterium begins colonizing the skin shortly after birth, while more stable and abundant colonization develops during the 1–3 years preceding puberty.
• Increase after puberty: As sebaceous gland activity increases around puberty, the density of C. acnes rises markedly. Reported bacterial counts increase from fewer than 10 cells/cm² to approximately 10⁶ cells/cm² on areas such as the face and upper trunk.
• Preferred anatomical sites: C. acnes preferentially colonizes lipid-rich, sebum-producing areas of the skin, particularly the:
• Nose
• Face
• Shoulders
• Back
• Upper chest and thorax
• Phylotype diversity: C. acnes is genetically diverse and consists of several distinct phylotypes. Major groups include type I (IA, IA1, IA2, IB, and IC), type II, and type III in commonly used classification schemes.
• Association of phylotypes with acne: Among acne-associated isolates, phylotype IA1 has been reported as the predominant group, accounting for approximately 71.4% of strains in the cited study, followed by IA2 and type III.
• Distribution beyond acne: Phylotype IA1 is also widely detected on healthy skin and in implant-associated infections, indicating that its presence alone does not establish disease. The disease-associated behavior of C. acnes is influenced by strain characteristics, host factors, microbial community composition, and local environmental conditions.
• Worldwide distribution: C. acnes occurs in human populations worldwide and is not restricted to a particular geographic or ethnic population.

Key epidemiological point: C. acnes is a nearly universal component of human skin microbiota. Therefore, the presence of the bacterium alone does not explain acne or other infections; differences in phylotype, microbial ecology, host factors, and local conditions are important when considering its role in disease.

Pathogenesis of Cutibacterium acnes

• Role in acne pathogenesis: Cutibacterium acnes, formerly known as Propionibacterium acnes, is a normal skin commensal that contributes to the pathogenesis of acne vulgaris alongside other major factors, particularly increased sebum production (seborrhea), hyperkeratinization of the pilosebaceous unit, and inflammation.
• Normal skin colonizer: C. acnes is a near-ubiquitous member of the human skin microbiota and is commonly associated with sebaceous glands and lipid-rich areas of the skin. It is a slow-growing, anaerobic/aerotolerant, non-spore-forming Gram-positive bacterium.
• Improved detection with prolonged culture: Because C. acnes grows slowly, conventional short-duration cultures may fail to detect it. Prolonged agar culture for approximately 14 days, together with techniques such as tissue sonication, can improve recovery of the organism, particularly from implant-associated infections.
• Extended incubation for implant-associated infections: Some investigators recommend incubation periods of up to 21 days to increase the yield of positive cultures because C. acnes may be present in low numbers and grow slowly.
• Diagnostic challenges of prolonged culture: Although extended incubation can improve detection, it can also:
• Delay microbiological diagnosis and initiation of appropriate treatment.
• Increase the opportunity for culture contamination.
• Make interpretation difficult because prolonged incubation may result in false-positive or clinically insignificant growth.
• Create a diagnostic challenge, particularly when C. acnes is isolated from normally sterile clinical specimens.

Multifactorial Pathogenesis

• The pathogenic potential of C. acnes is multifactorial and involves several interconnected mechanisms:
• Biofilm formation
• Host immune activation
• Phylotype-specific virulence
• Adaptation to specific local environments, including lipid-rich pilosebaceous follicles and implanted medical devices
• Transition from commensal to opportunistic pathogen: Although C. acnes normally exists as a harmless skin commensal, it can become an opportunistic pathogen when local or host conditions favor infection. This is particularly important in implant-associated infections, where the bacterium can colonize artificial surfaces.

Biofilm Formation

• Biofilm formation is a major mechanism of persistence: C. acnes can produce an extracellular polymeric matrix that allows bacterial cells to adhere to abiotic surfaces, including implanted medical devices.
• Protection within biofilms: The biofilm matrix provides protection against antimicrobial agents and host immune defenses, allowing bacterial cells to persist despite treatment and immune surveillance.
• Material-dependent biofilm characteristics: The composition and properties of the C. acnes biofilm can vary according to the material and surface of the infected implant, potentially influencing bacterial adherence and persistence.
• Chronic implant-associated infections: Biofilm-mediated persistence helps explain the indolent and chronic nature of many C. acnes implant-associated infections. Because bacterial growth and inflammation may be limited, clinical manifestations can appear months or even years after surgery.

Host Immune Activation and Inflammation

• Inflammatory tissue damage in acne: In acne vulgaris, tissue injury is driven largely by the host inflammatory response rather than simply by the physical presence or multiplication of C. acnes.
• Recognition by immune receptors: Components of C. acnes can activate Toll-like receptors (TLRs) on host immune cells, initiating intracellular signaling pathways that promote inflammatory responses.
• Pro-inflammatory cytokines: Activation of these immune pathways promotes the production of inflammatory mediators, including:
• Interleukin-1 (IL-1)
• Interleukin-6 (IL-6)
• Tumor necrosis factor-alpha (TNF-α)
• These inflammatory mediators contribute to follicular inflammation and tissue damage associated with acne.

Phylotype-Specific Virulence

• Phylotypic diversity influences pathogenicity: Not all C. acnes strains have identical biological or immunological properties. Differences between phylotypes can influence their association with health or disease and their ability to stimulate host immune responses.
• Acne-associated phylotypes: Acne-associated type IA strains, particularly IA1, have been reported to stimulate stronger inflammatory responses, including increased production of interferon-gamma (IFN-γ) and interleukin-17 (IL-17).
• Healthy-skin-associated phylotypes: In contrast, phylotypes more commonly associated with healthy skin can promote comparatively anti-inflammatory responses, including increased IL-10 production.
• Overall mechanism: Therefore, acne is not simply caused by the presence of C. acnes. Instead, disease development reflects interactions among sebaceous activity, follicular hyperkeratinization, bacterial strain/phylotype characteristics, biofilm formation, and host immune responses.

Virulence Factors of Cutibacterium acnes

• Strain-specific virulence: Phylogenetic studies suggest that acquired DNA sequences and bacterial immune-related elements may contribute to differences in virulence among C. acnes strains. Biochemical, transcriptomic, and proteomic studies have demonstrated that different phylotypes vary in their inflammatory potential and expression of putative virulence factors, which may help explain their different associations with acne and other infections.
• Major putative virulence factors: Important factors implicated in C. acnes pathogenicity include:
• CAMP factors
• Porphyrins
• Lipases
• Neuraminidase
• Hyaluronate lyase
• Polyunsaturated fatty acid (PUFA) isomerase
• Heat shock proteins
• Hemolysins
• Dermatan sulfate-binding adhesins
• Other factors involved in bacterial adhesion and modulation of host immune responses

1. CAMP Factors

• C. acnes strains possess five CAMP factor genes (CAMP1–CAMP5), which encode proteins with membrane-interacting and pore-forming activities that may contribute to host-cell damage.
• Cytotoxic and inflammatory effects: CAMP proteins have been implicated in damage to host cells, including keratinocytes and macrophages, potentially contributing to local tissue injury and inflammation.
• CAMP1 and TLR2: In vitro studies suggest that CAMP1 may interact with Toll-like receptor 2 (TLR2) and amplify host inflammatory signaling, thereby contributing to the inflammatory response associated with acne.
• Phylotype-dependent expression: Expression of CAMP factors varies among C. acnes phylotypes:
• CAMP1 expression has been reported to be particularly high in type IB and type II strains.
• CAMP2 has been detected at higher levels in type IA isolates.

2. Porphyrins

• C. acnes produces porphyrins, which may contribute to the perifollicular inflammatory response associated with acne.
• Generation of reactive oxygen species: Under ultraviolet (UV) exposure, porphyrins can participate in the generation of singlet oxygen and other reactive oxygen species, promoting oxidative reactions.
• Squalene oxidation: These oxidative processes may contribute to the formation of squalene peroxide, a pro-inflammatory lipid that can enhance follicular inflammation.
• Effects on keratinocytes: C. acnes-derived porphyrins may also stimulate keratinocytes to produce inflammatory mediators such as:
• Interleukin-8 (IL-8)
• Prostaglandin E2 (PGE2)
• These mediators can contribute to local inflammation and immune activation during acne development.

3. Hyaluronate Lyase

• Hyaluronate lyase is an extracellular enzyme whose genetic variants or alleles differ among C. acnes phylotypes.
• The enzyme can degrade hyaluronic acid, an important component of the extracellular matrix.
• Along with other tissue-degrading enzymes, hyaluronate lyase may facilitate disruption of extracellular-matrix components, including hyaluronic acid and other glycosaminoglycans, potentially promoting the spread of inflammation within affected skin tissue.

4. Polyunsaturated Fatty Acid Isomerase

• C. acnes produces polyunsaturated fatty acid (PUFA) isomerase, an enzyme involved in the modification of fatty acids.
• The enzyme has been characterized as a yellow, 424-amino-acid monomeric protein capable of catalyzing the isomerization of conjugated linoleic acid (CLA).
• CLA and its isomers can influence several physiological processes in humans and are also present at low concentrations in foods.
• Multiple PUFA-related proteins or candidate sequences have been identified in C. acnes, suggesting potential for studying these enzymes through recombinant expression and biochemical characterization.
• Although PUFA isomerase has been identified in C. acnes, its precise contribution to virulence and its expression patterns among different phylotypes remain unclear and require further investigation.

5. Lipases

• Lipases are important potential virulence factors because C. acnes colonizes sebum-rich pilosebaceous follicles and can metabolize host lipids.
• Lipase activity has been associated with acne severity, with some phylotype I strains showing higher lipolytic activity.
• Lipid metabolism can contribute to the production of short-chain fatty acids, including propionic and butyric acids, which may influence the local follicular environment and inflammatory responses.
• Proteomic analysis of human sebaceous follicle infundibula identified at least 12 putative lipases associated with C. acnes.
• Among these, GehA and GehB possess signal peptides consistent with secretion, suggesting that they may have particularly important extracellular functions.
• Different C. acnes phylotypes may produce distinct lipase profiles, potentially contributing to differences between health-associated and acne-associated strains. However, the specific roles of individual lipases require further investigation.

6. Adhesion-Associated Factors

• The acne-associated phylotype IA1 contains genetic features that may enhance bacterial adhesion and pathogenicity.
• These include a plasmid containing a tight-adhesion locus and two distinctive genomic islands carrying genes proposed to contribute to:
• Increased bacterial adhesion
• Host interaction
• Immune modulation
• Enhanced virulence
• Improved adhesion may facilitate persistence within the pilosebaceous unit and potentially on implanted medical devices.

7. Neuraminidase, Hemolysins and Dermatan Sulfate-Binding Adhesins

• Neuraminidase: This enzyme may modify host cell-surface glycoconjugates and contribute to interactions between C. acnes and host tissues.
• Hemolysins: These host-interacting proteins have been identified as potential contributors to cellular injury and inflammatory responses.
• Dermatan sulfate-binding adhesins: These surface-associated factors may promote attachment to host extracellular-matrix components, facilitating colonization and persistence.
• The exact contribution of these factors to disease varies among strains and remains an area of ongoing investigation.

8. Heat Shock Proteins

• C. acnes produces heat shock proteins (HSPs) that are involved primarily in cellular stress responses and protein homeostasis.
• Some heat shock proteins can also interact with the host immune system and may contribute indirectly to immune activation and inflammatory responses.

Key point: The virulence of C. acnes is phylotype- and strain-dependent. Its nearly universal presence on human skin means that pathogenicity cannot be explained simply by bacterial abundance; differences in genetic composition, expressed virulence factors, host interactions, and local skin conditions are critical.

Clinical Manifestations of Cutibacterium acnes

• Cutibacterium acnes is primarily a commensal skin bacterium, but it can act as an opportunistic pathogen when local or host conditions favor infection.
• Clinical manifestations range from common inflammatory skin disease, particularly acne vulgaris, to indolent postoperative and implant-associated infections.
• Unlike many acute bacterial infections, C. acnes infections often develop slowly and insidiously.
• Fever and other systemic symptoms are relatively uncommon, particularly in implant-associated infections, which can make diagnosis challenging.
• Important clinical conditions associated with C. acnes include:
• Acne vulgaris
• Progressive macular hypopigmentation
• Acne fulminans
• Surgical and postoperative infections
• Prosthetic joint infections
• Cardiac device-associated infections
• Neurosurgical shunt infections
• Other implanted-device infections

1. Acne Vulgaris

• Acne vulgaris is the most common clinical manifestation associated with C. acnes.
• Acne develops through multiple interacting mechanisms, including:
• Increased sebum production
• Follicular hyperkeratinization
• Alterations in the C. acnes population
• Activation of inflammatory and immune pathways
• C. acnes is adapted to the lipid-rich environment of sebaceous follicles and can utilize components of sebum as nutrients.
• Increased sebum production creates a favorable environment for bacterial persistence and changes within the pilosebaceous unit.
• The interaction between C. acnes, sebum, follicular changes, and host inflammatory responses contributes to the development of erythematous inflammatory papules, pustules, and other characteristic acne lesions.

2. Other Skin-Associated Diseases

Progressive Macular Hypopigmentation

• C. acnes has been investigated as a possible contributor to progressive macular hypopigmentation (PMH).
• PMH is characterized by non-scaly, hypopigmented macules that occur predominantly in sebaceous areas of the skin.
• The lower back is a commonly affected site.
• The precise role of C. acnes in PMH remains under investigation.

Acne Fulminans

• C. acnes may also contribute to acne fulminans, a rare and severe form of inflammatory acne.
• Acne fulminans can present with painful, ulcerating lesions and may be accompanied by systemic manifestations.
• It represents a much more severe inflammatory presentation than typical acne vulgaris.

3. Implant-Associated and Postoperative Infections

• C. acnes is increasingly recognized as an important cause of indolent surgical and implant-associated infections.
• It can infect implanted medical devices and prosthetic materials, where its ability to form biofilms promotes long-term persistence.
• The organism is increasingly detected in implant-associated infection specimens compared with earlier reports.
• This apparent increase is likely influenced partly by improvements in microbiological sampling and diagnostic techniques rather than necessarily representing a true increase in disease incidence.
• One important diagnostic advance is sonication of removed prosthetic material or medical devices before microbiological culture.
• Sonication can disrupt biofilms attached to implant surfaces and release bacteria into the surrounding fluid, thereby increasing bacterial recovery during culture.

4. Prosthetic Joint Infections

• C. acnes is associated with approximately 10% of prosthetic joint infections (PJIs) in some reported series.
• It is particularly associated with late and chronic infections, reflecting its slow-growing and biofilm-forming characteristics.
• The shoulder is the most frequent site of C. acnes isolation among prosthetic joint infections.
• The high frequency in shoulder infections may be related to greater colonization of the axillary region compared with anatomical sites such as the hip and knee.
• C. acnes is also recognized as an opportunistic pathogen in latent or delayed postoperative infections associated with spinal instrumentation.

5. Cardiac Device-Related Infections

• C. acnes can cause infections involving cardiovascular prosthetic and implanted devices.
• Reported infections include:
• Prosthetic heart valves
• Prosthetic valve rings
• Permanent pacemakers
• Implantable cardioverter-defibrillators (ICDs)
• These infections can be difficult to recognize because of the organism's slow growth, biofilm formation, and frequently subtle clinical presentation.

6. Neurosurgical Shunt Infections

• C. acnes is increasingly recognized as an opportunistic pathogen in neurosurgical procedures, particularly infections involving cerebrospinal fluid (CSF) shunt systems.
• It may account for approximately 15% of infections associated with shunt tubing devices in some reported studies.
• These devices drain CSF from the cerebral ventricles to another body compartment, most commonly the peritoneal cavity.
• Clinical manifestations of C. acnes shunt infections are often nonspecific.
• Fever may be absent, making these infections particularly difficult to distinguish from other causes of shunt malfunction or postoperative complications.
• The slow-growing nature of C. acnes and the need for prolonged culture further contribute to diagnostic difficulty.

Key point: C. acnes can cause both common inflammatory skin disease and clinically important deep infections. Its implant-associated infections are typically slow-growing, biofilm-associated, chronic, and relatively non-inflammatory, with fever often absent. These characteristics can result in delayed diagnosis, particularly when prolonged culture is required for bacterial recovery.

Laboratory Diagnosis of Cutibacterium acnes

1. Specimen Collection and Transport

• Appropriate clinical specimens depend on the suspected site of infection and may include:
• Periprosthetic tissue
• Synovial fluid
• Cerebrospinal fluid (CSF)
• Explanted prosthetic or implanted medical devices
• Sonication fluid from removed implants, when applicable
• Because C. acnes is a slow-growing anaerobic bacterium, specimens should be collected carefully and transported promptly to the microbiology laboratory.
• Specimens intended for anaerobic culture should be placed in appropriate sterile anaerobic transport containers and handled according to the laboratory's validated anaerobic specimen-transport protocol.

2. Gram Staining

• Gram staining can provide an initial microscopic clue to the presence of C. acnes.
• The organism typically appears as:
• Gram-positive
• Pleomorphic
• Non-spore-forming
• Short bacillary or diphtheroid-like cells
• Arranged singly, in pairs, or in small clusters
• However, Gram staining alone is not sufficient for definitive identification, particularly because C. acnes can be present in low numbers in clinical specimens.

3. Culture

• Culture remains an important method for recovering C. acnes from clinical specimens.
• C. acnes is a slow-growing, anaerobic, relatively aerotolerant organism, and its growth is considerably slower than that of many common bacterial pathogens.
• Its reported generation time is approximately 5.1 hours, contributing to its slow development in culture.
• Because of its slow growth, prolonged incubation is essential for maximizing recovery.
• Depending on the specimen and laboratory protocol, cultures may require:
• A minimum incubation period of approximately 6 days
• Extension of incubation to up to 14 days when C. acnes infection is suspected
• Short incubation periods can result in false-negative cultures, particularly in implant-associated and other indolent infections.

Thioglycolate Broth

• Thioglycolate broth can support the growth of C. acnes and may be useful for recovering the organism from clinical specimens.
• In some infections, growth may become detectable only after prolonged incubation. For example, C. acnes cultures from cases of infectious keratitis have been reported to become positive after approximately 7 days of incubation.

4. MALDI-TOF Mass Spectrometry

• Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) has significantly improved the rapid identification of C. acnes from positive cultures.
• The technique identifies microorganisms by analyzing their characteristic protein spectral profiles and comparing them with reference databases.
• Major advantages include:
• Rapid identification
• Reliable species-level identification in many routine isolates
• Improved differentiation of C. acnes from other bacterial isolates
• However, identification should be interpreted together with the clinical context and quality of the reference database.
• Closely related Cutibacterium species, such as C. namnetense and C. modestum, may occasionally create identification challenges. In uncertain cases, molecular confirmation or additional identification methods may be required.

5. Molecular Methods

• Polymerase Chain Reaction (PCR) provides a sensitive approach for detecting C. acnes DNA directly in clinical specimens.
• Broad-range or universal 16S rRNA gene PCR can be particularly useful when:
• Culture results are negative despite strong clinical suspicion.
• The patient has already received antimicrobial therapy.
• The bacterial load is low.
• Bacterial viability has been compromised.
• The organism needs to be detected directly from tissue or implant sonication fluid.
• Amplification and sequencing of bacterial 16S rRNA gene sequences can provide evidence of C. acnes when conventional culture fails to recover viable organisms.
• Molecular detection can therefore complement culture, particularly in indolent implant-associated infections.

6. Sonication in Implant-Associated Infections

• When an infected prosthesis or implanted device is removed, sonication can be used to dislodge bacteria embedded within biofilms on the implant surface.
• The resulting sonication fluid can then be subjected to culture and/or molecular testing.
• This approach can increase the likelihood of detecting organisms such as C. acnes, which may be present in low numbers within biofilms and may be difficult to recover using conventional tissue sampling alone.

7. Interpretation of Unexpected Positive Results

• Detection of C. acnes after an apparently aseptic implant revision or device replacement can create an important diagnostic and clinical challenge.
• Because C. acnes is a common skin commensal, a positive culture must be interpreted carefully to distinguish:
• True implant-associated infection
• Contamination during specimen collection or processing
• Clinically insignificant colonization
• When a previously unrecognized infection is detected only after implant revision, antimicrobial treatment may be initiated late, potentially increasing the risk of treatment failure and further complications.

Key point: Diagnosis of C. acnes infection requires awareness of its slow growth, anaerobic physiology, low bacterial burden, biofilm formation, and potential for contamination. Prolonged culture, appropriate specimen handling, implant sonication, MALDI-TOF MS, and molecular methods can work together to improve diagnostic accuracy.

Treatment of Cutibacterium acnes (Acne Vulgaris)

Treatment of acne vulgaris is multimodal and targets several pathogenic mechanisms, including C. acnes–associated inflammation, follicular hyperkeratinization, and excessive sebum production. Treatment selection depends on acne severity, lesion type, scarring risk, previous treatment response, and patient-specific factors.

1. Topical Treatments

Benzoyl Peroxide (BPO)

• Benzoyl peroxide is a first-line topical antimicrobial for acne.
• It rapidly reduces C. acnes through oxidative activity and does not rely on conventional antibiotic mechanisms.
• It is particularly useful in combination regimens because it can help reduce the development of antibiotic resistance.

Topical Retinoids

• Common topical retinoids include adapalene, tretinoin, and tazarotene.
• They normalize follicular keratinization, helping prevent formation of comedones.
• They also have anti-inflammatory effects and are important for both treating existing acne and preventing new lesions.
• Topical retinoids are commonly used as a foundation of long-term acne management.

Topical Antibiotics

• Clindamycin and, less commonly, erythromycin may be used for inflammatory acne.
• Topical antibiotics should not be used alone because monotherapy promotes the development of antimicrobial resistance.
• They are generally combined with benzoyl peroxide to improve treatment effectiveness and reduce the risk of antibiotic resistance.

2. Systemic Treatments

Oral Antibiotics

• Systemic antibiotics are used primarily for moderate-to-severe inflammatory acne, particularly when topical therapy alone is insufficient.
• Common options include:
• Doxycycline
• Minocycline
• Tetracycline
• Their benefits result from both antimicrobial and anti-inflammatory effects.
• Oral antibiotics should generally be used for a limited duration and alongside appropriate topical therapy, particularly benzoyl peroxide, to reduce antimicrobial resistance.

Isotretinoin

• Isotretinoin is an oral retinoid used for severe, scarring, or treatment-resistant acne.
• It acts on several major mechanisms involved in acne, including sebum production, follicular keratinization, inflammation, and C. acnes–supporting follicular conditions.
• Because of its significant adverse-effect profile and important pregnancy-related risks, isotretinoin requires careful medical supervision and appropriate monitoring.

Hormonal Therapy

• Hormonal treatment may be appropriate for selected female patients, particularly when hormonal factors contribute to acne.
• Options include:
• Combined oral contraceptives
• Spironolactone
• These treatments can reduce androgen-mediated sebaceous gland activity and sebum production, thereby improving acne in appropriately selected patients.

Prevention of Cutibacterium acnes

Prevention strategies differ according to the clinical setting. For acne vulgaris, prevention focuses on controlling follicular plugging, sebum-associated conditions, and C. acnes–associated inflammation. In surgical settings, preventive measures aim to reduce the bacterial burden on the skin and minimize the risk of implant-associated infection.

1. Acne Prevention

Over-the-Counter (OTC) Topical Products

• Products containing benzoyl peroxide (BPO) are commonly used as first-line topical therapy for mild acne.
• BPO releases reactive oxygen species that exert a rapid antimicrobial effect against C. acnes.
• Unlike conventional antibiotics, benzoyl peroxide does not promote bacterial resistance through a conventional antibiotic-resistance mechanism.
• It also helps prevent follicular obstruction and supports clearance of acne lesions.

Prescription Topical Retinoids

• For persistent or recurrent acne, dermatologists may prescribe topical retinoids such as adapalene, tretinoin, or tazarotene.
• Retinoids help prevent follicular plugging by normalizing keratinocyte turnover and follicular keratinization.
• They can therefore reduce the formation of new comedones and support long-term acne control.

2. Surgical and Hospital Prevention

Because C. acnes is a normal component of the skin microbiota, particularly in sebaceous and hair-bearing areas, preventing implant-associated infection requires effective reduction of the patient's skin bacterial burden before surgery.

Preoperative Decolonization

• Benzoyl peroxide (BPO) has been investigated as a preoperative skin-decolonization strategy, particularly before shoulder and other implant-related procedures.
• A commonly studied protocol involves applying 5% BPO preparations for several days before surgery, including regimens lasting approximately 5 days.
• BPO is useful because it can substantially reduce the cutaneous burden of C. acnes in sebaceous areas.

Surgical Site Preparation

• Appropriate preoperative skin antisepsis is an important component of surgical infection prevention.
• Protocols combining hydrogen peroxide followed by an alcohol-based chlorhexidine preparation such as ChloraPrep have been investigated for reducing the bacterial burden of C. acnes before shoulder surgery.
• The exact concentration, exposure time, and sequence should follow the institution's validated surgical antisepsis protocol, because hydrogen peroxide and chlorhexidine preparations are not interchangeable and inappropriate application can cause tissue injury.

Antibiotic Prophylaxis

• Intravenous cefazolin is commonly used for perioperative antimicrobial prophylaxis in shoulder arthroplasty when there is no contraindication or relevant allergy.
• Antibiotic prophylaxis should be selected according to current surgical guidelines, patient-specific risk factors, local resistance patterns, and institutional protocols.
• Intrawound vancomycin powder has also been investigated as an additional local preventive measure in some orthopedic procedures, but its routine use should be based on current evidence and institutional practice rather than considered universally necessary.

References

• Boisrenoult, P. (2018). Cutibacterium acnes prosthetic joint infection: Diagnosis and treatment. Orthopaedics & Traumatology: Surgery & Research, 104(1S), S19–S24. https://doi.org/10.1016/j.otsr.2017.05.030
• Dréno, B. (2016). Bacteriological resistance in acne: A call to action. European Journal of Dermatology, 26(2), 127–132. https://doi.org/10.1684/ejd.2015.2685
• Dréno, B., Pécastaings, S., Corvec, S., Veraldi, S., Khammari, A., & Roques, C. (2018). Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: A brief look at the latest updates. Journal of the European Academy of Dermatology and Venereology, 32(Suppl. 2), 5–14. https://doi.org/10.1111/jdv.15043
• Fitz-Gerald, P. T., Stamer, D. K., Wyles, C. C., & Houdek, M. T. (2019). Reduced time to positive Cutibacterium acnes culture utilizing a novel incubation technique: A retrospective cohort study. Journal of Shoulder and Elbow Arthroplasty, 3, 2471549219840823. https://doi.org/10.1177/2471549219840823
• Jeon, J. H., & Lee, J. W. (2019). Epidemiological survey of Cutibacterium acnes involved in acne in healthy individuals. Journal of the Japan Society of Acne Research, 68(2), 339–346. https://www.jstage.jst.go.jp/article/jamt/68/2/68_18-91/_article/-char/en
• Mayslich, C., Grange, P. A., & Dupin, N. (2021). Cutibacterium acnes as an opportunistic pathogen: An update of its virulence-associated factors. Microorganisms, 9(2), 303. https://doi.org/10.3390/microorganisms9020303
• Mohammed, E. R., Baqer, L. K., & Dhaher, S. A. (2025). Isolation and prevalence of Cutibacterium acnes phylotypes among acne patients. Romanian Journal of Medical Practice, 20(4), 374–380. https://doi.org/10.37897/RJMP.2025.4.6
• Niedźwiedzka, A., Mękal, M. P., Borzęcka, M., & Płatek, C. (2024). The role of the skin microbiome in acne: Challenges and future therapeutic opportunities. International Journal of Molecular Sciences, 25(21), 11422. https://doi.org/10.3390/ijms252111422
• Parente, J. N., Ormond, D. T., Cherian, N. J., & Miller, M. D. (2026). Cutibacterium acnes culture isolation following total hip and total knee arthroplasty. Antibiotics, 15(2), 165. https://doi.org/10.3390/antibiotics15020165
• Platsidaki, E., & Dessinioti, C. (2018). Recent advances in understanding Propionibacterium acnes (Cutibacterium acnes) in acne. F1000Research, 7, F1000 Faculty Rev-1953. https://doi.org/10.12688/f1000research.15659.1
• Pu, M., & Garrett, E. M. (2023, November 10). Cutibacterium acnes. PathologyOutlines.com. https://www.pathologyoutlines.com/topic/microcutibacteriumacne.html
• Sanford, J. A., & Gallo, R. L. (2013). Functions of the skin microbiota in health and disease. Seminars in Immunology, 25(5), 370–377. https://doi.org/10.1016/j.smim.2013.09.005
• Siddiqui, R., Makhlouf, Z., & Khan, N. A. (2022). The increasing importance of the gut microbiome in acne vulgaris. Folia Microbiologica, 67(6), 825–835. https://doi.org/10.1007/s12223-022-00982-5
• Tomida, S., Nguyen, L., Chiu, B. H., Liu, J., Sodergren, E., Weinstock, G. M., & Li, H. (2013). Propionibacterium acnes strain populations in the human skin microbiome associated with acne. Journal of Investigative Dermatology, 133(9), 2152–2160. https://doi.org/10.1038/jid.2013.21
• Wickham Micro. (2018, July 9). Fact sheet: Cutibacterium acnes. https://wickhammicro.co.uk/knowledge-and-education/cutibacterium-acnes
• Yoon, Y. J., & Lee, J. W. (2018). Comparative lipidomic profiling of the human commensal bacterium Propionibacterium acnes and its extracellular vesicles. RSC Advances, 8(27), 15241–15247. https://doi.org/10.1039/c7ra13769a